In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Lipid-lowering therapy beyond LDL Cholesterol
Session

Event : ESC Congress 2018

Topic : Lipids

  • Session type : Symposium
  • Date : 26 August 2018
  • Time : 10:30 - 12:00

4 presentations in this session

Triglyceride-rich lipoproteins in secondary prevention: do we need to treat?

Event : ESC Congress 2018

  • Session : Lipid-lowering therapy beyond LDL Cholesterol
  • Speaker : J Chapman (Saint Maur,FR)

Lp(a): Is there any benefit from reducing it?

Event : ESC Congress 2018

  • Session : Lipid-lowering therapy beyond LDL Cholesterol
  • Speaker : BA Ference (Cambridge,GB)

Is it time to sing the requiem for HDL cholesterol?

Event : ESC Congress 2018

  • Session : Lipid-lowering therapy beyond LDL Cholesterol
  • Speaker : U Laufs (Leipzig,DE)

Does LDL induce inflammation? If so, does it matter?

Event : ESC Congress 2018

  • Session : Lipid-lowering therapy beyond LDL Cholesterol
  • Speaker : JW Jukema (Leiden,NL)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are